RE:RE:Oh oh somthings happening here... :)Righttothetop wrote: Nah...this is just the stupid people piling into cannabis because of the favourable US voting in a number of states.
Pretty much meaningless...although I won't say I'm not happy to see a green day for a change. Could also be the standard pre-financial run-up....which the 'flad' alter-ego would claim is a perfect time to short.
That said, I think the previous post from Hound summed it up nicely on where LABS goes from here in 2021 and beyond....
1hot-techwoman wrote: GLTA
Get bent...LOL better sell than :) Canaccord Genuity Raises Medipharm Labs Price Target To C$2.50 October 6, 2020 1:29 PM Justin Young 0 Comments Analyst Estimate, Medipharm Labs k Share N Tweet s Share On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European pharmaceutical company STADA. Under the agreement, Medipharm will supply GMP certified medical cannabis, manufacturing, logistics, and regulatory support to STADA. At the same time, STADA will be responsible for commercializing cannabis products, which will initially be sold in Germany. STADA CEO Peter Goldschmidt commented in yesterdays release, This partnership with MediPharm demonstrates STADAs ambition to be the go-to-partner for Generics, Consumer Health, and Specialty Products. With MediPharm, we are collaborating with a very strong partner in the Medical Cannabis field.